HenryQXiongMD

PubMed

• 41 citations
  Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)
  Herbert Hurwitz, Benjamin R. Tan, James A. Reeves, Henry Xiong, Brad Somer, Heinz-Josef Lenz, Howard S. Hochster, Frank A. Scappaticci, John F. Palma, Richard Price, J...> ;The Oncologist. 2019 Jul 1
• 1 citations
  Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
  Kamalesh Kumar Sankhala, Chris H. Takimoto, Alain C. Mita, Henry Xiong, Jordi Rodon, Amir Mehrvarz Sarshekeh, K. Burns, Kenzo Iizuka, Scott Kopetz> ;Investigational New Drugs. 2019 Feb 1
• 1 citations
  Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer
  Amir Mehrvarz Sarshekeh, Henry Q. Xiong, Kenzo Iizuka, Howard S. Hochster, Scott Kopetz> ;Investigational New Drugs. 2018 Jun 13
• 65 citations
  Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers
  Yunfeng Yan, Hu Xiong, Xinyi Zhang, Qiang Cheng, Daniel J. Siegwart> ;Biomacromolecules. 2017 Nov 27
• 37 citations
  A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
  Andrew H. Ko, Patrick B. Murphy, James D. Peyton, Dianna Shipley, Ahmed Al-Hazzouri, Francisco Antonio Rodriguez, Mark Sanders Womack, Henry Q. Xiong, David M. Waterho...> ;The Oncologist. 2017 Dec 1
• The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.
  Li G, Li M, Hu J, Lei R, Xiong H, Ji H, Yin H, Wei Q, Hu G> ;Oncogene. 2016-09-19
• 41 citations
  Activatable Water-Soluble Probes Enhance Tumor Imaging by Responding to Dysregulated pH and Exhibiting High Tumor-to-Liver Fluorescence Emission Contrast.
  Hu Xiong, Petra Kos, Yunfeng Yan, Kejin Zhou, Jason B. Miller, Sussana Elkassih, Daniel J. Siegwart> ;Bioconjugate Chemistry. 2016 Jun 20
• 24 citations
  Tumor Imaging Based on Photon Upconversion of Pt(II) Porphyrin Rhodamine Co-modified NIR Excitable Cellulose Enhanced by Aggregation
  Atsushi Nagai, Jason B. Miller, Petra Kos, Sussana Elkassih, Hu Xiong, Daniel J. Siegwart> ;ACS Biomaterials Science & Engineering. 2015 Nov 3
• Correction: TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome.
  Sun T, Du W, Xiong H, Yu Y, Weng I, Ren L> ;Clin. Cancer Res.. 2015-08-01
• 5 citations
  SNPs in Entire Mitochondrial Genome Sequences (≈15.4 kb) and cox1 Sequences (≈486 bp) Resolve Body and Head Lice From Doubly Infected People From Ethiopia, China, Nepa...
  H. Xiong, Dayana Campelo, Amina Boutellis, Didier Raoult, M. Alem, Jemal Ali, Kassahun Desalegn Bilcha, Renfu Shao, Richard J. Pollack, Stephen C. Barker> ;Journal of Medical Entomology. 2014 Nov 1
• Racial disparities in the association between diabetes mellitus-associated polymorphic locus rs4430796 of the HNF1β gene and prostate cancer: a systematic review and m...
  Xiang YZ, Jiang SB, Zhao J, Xiong H, Cui ZL, Li GB, Jin XB> ;Genet. Mol. Res.. 2014-08-28
• 7 citations
  Second-generation sequencing of entire mitochondrial coding-regions (∼15.4 kb) holds promise for study of the phylogeny and taxonomy of human body lice and head lice.
  H. Xiong, Dayana Campelo, Richard J. Pollack, Didier Raoult, Renfu Shao, M. Alem, Jemal Ali, Kassahun Desalegn Bilcha, Stephen C. Barker> ;Medical and Veterinary Entomology. 2014 Aug 1
• Misdiagnosis and long-term outcome of 13 patients with acute thallium poisoning in China.
  Li JM, Wang W, Lei S, Zhao LL, Zhou D, Xiong H> ;Clin Toxicol (Phila). 2014-03-01
• 19 citations
  Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial
  David R. Fogelman, Mehrdad Jafari, Gauri R. Varadhachary, Henry Xiong, Susie Bullock, Harold Ozer, E. Lin, Jeffrey S. Morris, Patti Cunningham, Bronwyn Bennett, James ...> ;Cancer Chemotherapy and Pharmacology. 2011 Apr 9
• 141 citations
  Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
  Milind Javle, Rachna T. Shroff, Henry Xiong, G. Varadhachary, David R. Fogelman, Shrikanth A.G. Reddy, Darren W. Davis, Yujian Zhang, Robert A. Wolff, James L. Abbruzzese> ;BMC Cancer. 2010 Jul 14
• Change of HA molecular size and boundary lubrication in synovial fluid of patients with temporomandibular disorders.
  Wei L, Xiong H, Li B, Gong Z, Li J, Cai H, Meng Q, Long X> ;J Oral Rehabil. 2010-04-01
• Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.
  Li J, Yang L, Song L, Xiong H, Wang L, Yan X, Yuan J, Wu J, Li M> ;Oncogene. 2009-09-10
• Inhibition of mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: The results of two prospective phase II studies.
  Javle MM, Xiong H, Reddy S, Bhosale P, Davis D, Varadhachary G, Fogelman D, Kaseb A, Wolff RA, Abbruzzese JL> ;J. Clin. Oncol.. 2009-05-20
• ABT-263 activity and safety in patients with relapsed or refractory lymphoid malignancies in particular chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (...
  Wilson W, O'Connor OO, Roberts AW, Czuczman M, Brown J, Xiong H, Xiong H, Chiu Y, Krivoshik A, Enschede S, Humerickhouse R> ;J. Clin. Oncol.. 2009-05-20
• Ongoing phase I studies of ABT-263: Mitigating Bcl-XL induced thrombocytopenia with lead-in and continuous dosing.
  Roberts AW, Wilson W, Gandhi L, O'Connor OA, Rudin CM, Brown JR, Xiong H, Chiu Y, Enschede S, Krivoshik AP> ;J. Clin. Oncol.. 2009-05-20
• 117 citations
  Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.
  Henry Q. Xiong, Gauri R. Varadhachary, Joan C. Blais, Kenneth R. Hess, James L. Abbruzzese, Robert A. Wolff> ;Cancer. 2008 Oct 15
• 54 citations
  Phase I Clinical Study of Three Times a Day Oral Administration of TAS-102 in Patients with Solid Tumors
  Michael J. Overman, Scott Kopetz, Gauri R. Varadhachary, Masakazu Fukushima, Keizo Kuwata, Akira Mita, Robert A. Wolff, Paulo M. Hoff, Henry Xiong, James L. Abbruzzese> ;Cancer Investigation. 2008 Oct 1
• 353 citations
  Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
  Gauri R. Varadhachary, Robert A. Wolff, Christopher H. Crane, Charlotte C. Sun, Jeffrey E. Lee, Peter W.T. Pisters, Jean Nicolas Vauthey, Eddie K. Abdalla, Huamin Wang...> ;Journal of Clinical Oncology. 2008 Jul 20
• 66 citations
  Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors
  Michael J. Overman, Gauri R. Varadhachary, Scott Kopetz, Melanie B. Thomas, Masakazu Fukushima, Keizo Kuwata, Akira Mita, Robert A. Wolff, Paulo M. Hoff, Henry Xiong, ...> ;Investigational New Drugs. 2008 Jun 5
• A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies.
  Wilson WH, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, Dunleavy K, Krivoshik AP, Xiong H, Chiu Y, O'Connor OA> ;J. Clin. Oncol.. 2008-05-20
• Join now to see all